echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Beijing Biochem Ivabradine Hydrochloride Tablets Will Be Approved

    Beijing Biochem Ivabradine Hydrochloride Tablets Will Be Approved

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the official website of NMPA showed that the application for the listing of the 4 generic generic drug "ivabradine hydrochloride tablets" by Beijing Biopharmaceuticals has entered the approval status (registration number: CYHS1900783), and it is expected to be approved soon and become the first imitation in China.


    Ivabradine is a purely heart rate-lowering drug that reduces heart rate by selectively and specifically inhibiting the If current of cardiac pacing.


    At present, only the original research product ivabradine hydrochloride tablets is on the market in China.


    Source: Insight database (http://db.


    Beijing Baiao Pharmaceutical was founded by the Chinese Academy of Sciences on January 19, 1995 with a registered capital of 55 million yuan.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.